Raleigh, NC, United States of America

Jesse M Jaynes

USPTO Granted Patents = 46 

 

 

Average Co-Inventor Count = 2.3

ph-index = 14

Forward Citations = 610(Granted Patents)


Location History:

  • Baton Rouge, LA (US) (1994 - 2004)
  • Raleigh, NC (US) (1996 - 2012)
  • Auburn, CA (US) (2018)
  • Auburn, AL (US) (2007 - 2023)
  • Tuskegee, AL (US) (2022 - 2024)

Company Filing History:


Years Active: 1994-2025

Loading Chart...
Loading Chart...
Loading Chart...
46 patents (USPTO):Explore Patents

Title: Innovations by Jesse M. Jaynes: Pioneering Advances in Biotechnology

Introduction

Jesse M. Jaynes, based in Raleigh, NC, is an accomplished inventor with an impressive portfolio of 26 patents. His work primarily focuses on innovations in biotechnology, particularly in developing transgenic crops and therapeutic peptides. Jaynes’ contributions have significantly advanced scientific understanding in areas related to agriculture and health.

Latest Patents

Jaynes' recent patents include the development of transgenic corn that expresses the antifungal peptide AGM182. This innovation addresses the challenges posed by aflatoxigenic fungi, which adversely affect maize and other crops by producing hazardous aflatoxins. In vitro studies indicate that AGM182 exhibits a five-fold increase in antifungal activity compared to tachyplesin1, demonstrating its potential to mitigate fungal growth. His work has shown significant reductions in fungal infection; specifically, the transgenic maize displaying AGM182 yielded a 72% decrease in fungal growth when tested against a highly aflatoxigenic fungal strain.

Another notable patent revolves around ligand/lytic peptide methods. These amphipathic lytic peptides are designed to selectively target and inhibit cells reliant on specific ligand interactions. This technology holds promise for various applications, including long-term contraception, tumor treatment, and the selective lysis of virally-infected or autoimmune disease-associated lymphocytes. The mechanism involves the combination of a ligand, such as gonadotropin-releasing hormone, with membrane-active lytic peptides to achieve rapid cell lysis, which could be transformative in gene therapy strategies for treating tumors and other diseases.

Career Highlights

Throughout his career, Jesse M. Jaynes has worked with innovative companies such as Demegen, Inc. and Helix Biomedix Inc. His relentless pursuit of groundbreaking technologies has solidified his reputation as a leader in biotechnological advancements.

Collaborations

Jaynes has collaborated with notable peers in the field, including Gordon R. Julian and Frederick M. Enright. Their collective efforts have fostered an environment of creativity and scientific discovery, leading to breakthroughs that enhance agricultural and medical science.

Conclusion

Jesse M. Jaynes is a remarkable inventor whose contributions continue to shape the fields of biotechnology and agriculture. His latest patents reflect his dedication to innovation and the potential to solve pressing challenges in food safety and health. As he continues to pioneer new solutions, Jaynes' work will undoubtedly inspire future generations of inventors in the realm of scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…